SCHEMBL10143872

SCHEMBL10143872

CN[C@@H](CC(CO)Cc1ccc(NC(=O)c2ccc(N)c(OC)c2)cc1)C(=O)CC1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
USP2 O75604 1/20 0.38
HTR4 Q13639 1/20 0.37
HPGD P15428 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
ROCK2 O75116 1/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 2/20 0.36
MAPT P10636 1/20 0.36
CYSLTR2 Q9NS75 1/20 0.36
CYSLTR1 Q9Y271 1/20 0.36
AAK1 Q2M2I8 1/20 0.35
PDE5A O76074 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10143826 0.72 PDE4D (0.46) PDE4APDE4BPDE4CPDE4DKMT2A
SCHEMBL5148402 0.68 MEN1 (0.60) KMT2AMEN1RAB9ANPC1USP2
SCHEMBL28034904 0.67 NPC1 (0.59) KMT2AMEN1RAB9ANPC1HPGD
SCHEMBL13175546 0.67 HTR4 (0.69) PDE4APDE4BPDE4CPDE4DKMT2A
SCHEMBL13175829 0.67 NPC1 (0.67) KMT2AMEN1RAB9ANPC1KDM4E
SCHEMBL11315443 0.67 NPC1 (0.60) KMT2AMEN1RAB9ANPC1USP2
SCHEMBL13175544 0.66 TDP1 (0.69) KMT2AMEN1HTR4HPGDLMNA
SCHEMBL14452805 0.66 HTR4 (0.48) PDE4APDE4BPDE4CPDE4DKMT2A
SCHEMBL18993437 0.66 MEN1 (0.54) KMT2AMEN1RAB9ANPC1USP2
SCHEMBL359029 0.65 MEN1 (0.68) PDE4APDE4BPDE4CPDE4DKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079743-B1 PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER CHROMA THERAPEUTICS LTD (GB) 2012-01-25 EP disclosed